Literature DB >> 4628903

Bacterial lipopolysaccharide: oral route for interferon production in mice.

J S Youngner.   

Abstract

Bacterial lipopolysaccharide given orally to mice in relatively small amounts produces significant amounts of circulating interferon.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4628903      PMCID: PMC422587          DOI: 10.1128/iai.6.4.646-647.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Interferon appearance stimulated by endotoxin, bacteria, or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis.

Authors:  J S Youngner; W R Stinebring
Journal:  Nature       Date:  1965-10-30       Impact factor: 49.962

2.  Interferon activity associated with high molecular weight proteins in the circulation of mice injected with endotoxin or bacteria.

Authors:  J V Hallum; J S Youngner; W R Stinebring
Journal:  Virology       Date:  1965-11       Impact factor: 3.616

3.  Tilorone hydrochloride: an orally active antiviral agent.

Authors:  R E Krueger; G D Mayer
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

4.  Tilorone hydrochloride: mode of action.

Authors:  G D Mayer; R F Krueger
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

5.  Interferon production by inactivated Newcastle disease virus in cell cultures and in mice.

Authors:  J S Youngner; A W Scott; J V Hallum; W R Stinebring
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

  5 in total
  2 in total

1.  Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota.

Authors:  Jennifer M Bates; Janie Akerlund; Erika Mittge; Karen Guillemin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

2.  Diet Matters: Endotoxin in the Diet Impacts the Level of Allergic Sensitization in Germ-Free Mice.

Authors:  Martin Schwarzer; Dagmar Srutkova; Petra Hermanova; Francois Leulier; Hana Kozakova; Irma Schabussova
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.